Browsing Blizard Institute by Title
Now showing items 1-20 of 5281
-
008 pp: beyond effectiveness: conducting qualitative research alongside a cluster randomised controlled trial of hiv testing in general practice.
(2015)I worked as a trial manager of a cluster randomized controlled trial of rapid HIV testing in primary care settings over a 2.5 year period. This left me with a number of questions that were unanswered by the trial design. ... -
10 minutes
(SAGE Publications, 2020-10) -
1157 Let’s talk air pollution – it’s everyones responsibility
(BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021-10) -
1174 THE ROLE OF HIP FRACTURE IN TRAJECTORIES OF DEPRESSIVE SYMPTOMS AMONG OLDER ADULTS: ANALYSIS FROM THE ENGLISH LONGITUDINAL STUDY
(Oxford University Press (OUP), 2023-01-16) -
132 Increased BMP Signalling Correlates with Increased Eczema Severity
(Elsevier, 2021-10) -
1332 Understanding the role of glycogen metabolism in human hair follicle biology
(Elsevier, 2018-05-01) -
13th Annual Fungal Update Conference Preface
(2019-06) -
14,17,18-Trihydroxy-Eicosatetraenoic Acid: A Novel Pro-Resolving Lipid Mediator from Marine Microalgae.
(2021-06-11)Specialized pro-resolving mediators (SPMs) are enzymatically oxygenated derivatives of polyunsaturated fatty acids that function as central immunoregulators in mammals. Among them are resolvins (Rvs) that stimulate the ... -
1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype
(American Diabetes Association, 2023-06-20) -
1531 MULTIPLE MODIFIABLE COMPONENTS OF HOSPITAL SERVICE DELIVERY PREDICT HIP FRACTURE: A NATIONAL RECORD-LINKAGE STUDY
(Oxford University Press (OUP), 2023-07-21) -
178 Atraumatic lumbar puncture campaign – effect on complications
(BMJ, 2022-06) -
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries.
(2018-10-04)In the 1960s and 70s, biochemical and pharmacological evidence was pointing toward glutamate as a synaptic transmitter at a number of distinct receptor classes, known as NMDA and non-NMDA receptors. The field, however, ... -
A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY-MS Baseline Analysis
(2020-04-14)Meeting Abstract 1487 from 72nd Annual Meeting of the American Academy of Neurology Toronto 25 April–1 May 2020